The 2025-26 RSV season is fast approaching. Please note the changes for the upcoming RSV season discussed below.
Synagis is an FDA-approved medication that helps protect high-risk babies’ lungs from severe RSV (Respiratory Syncytial Virus). As noted on their website, Synagis will be voluntarily discontinued and will no longer be available as of 12/31/25. Synagis will be phased out and will no longer be an option moving forward. For now, Beyfortus will replace Synagis as the RSV vaccine of choice adminstered in our clinic.
RSV symptoms present much like a moderate to severe cold. Premature babies and babies born with heart or lung conditions are at a higher risk of contracting RSV, which can lead to serious lung infections like bronchiolitis or pneumonia. Death from RSV in infants is 10 times greater than that of the flu.
An RSV vaccine can protect both premature and high-risk babies. Beyfortus is given ONCE during the RSV season (differing from Synagis which was given once a month), which runs from November through March here in Nevada. If your child has been given Beyfortus upon discharge from a hospital stay or they have already received a dose from their pediatrician or other healthcare provider for the current RSV season, they will not need another dose until the next RSV season, provided they still qualify to receive it.
| Our office has joined the Vaccines for Children Program (VFC), through which we have access to the RSV vaccine Beyfortus (Nirsevimab-alip). This vaccine is available to patients with Medicaid (FFS, Molina, Smartchoice, Silver Summit, Anthem) as their primary insurance. We have worked out a system to obtain and administer Beyfortus to patients with Health Plan of Nevada (HPN) and Sierra Health and Life (SHL). However, we still have no access to Beyfortus for patients with any commercial/private insurances (Aetna, Cigna, BCBS, UHC, Culinary, UMR etc.). For those patients, you will have to contact your pediatrician to see if they offer Beyfortus. If they do not offer Beyfortus, they will have to refer you to the Southern Nevada Health District (SNHD). We will no longer be referring patients to SNHD for Beyfortus, we will have you see your pediatrician and they will be able to refer you over to them. For Medicaid plans, Beyfortus does not need an authorization, but for HPN/SHL, we will need to obtain an authorization beforehand. We will update this page with any changes as they occur. We do not have any Beyfortus on-hand to purchase. |
For inquiries on either RSV vaccines, or if you are already in our program and you have any questions, you can email Brad, the RSV vaccine coordinator at: brad3820cls@gmail.com
